Multiple blade handle system
    41.
    发明授权

    公开(公告)号:US11013529B2

    公开(公告)日:2021-05-25

    申请号:US16515591

    申请日:2019-07-18

    Abstract: A handle system includes a body extending between a first end and a second end. The handle system also includes a slot extending, at least partially, in the body, the slot forming a cavity. The handle system further includes a carrier arranged, at least partially, within the slot, the carrier further comprising a friction locker and at least one arm coupled to the friction locker, the at least one arm being rotatable about the friction locker. The handle system also includes a cap arranged on at least one of the first end or the second end. The handle system further includes a blade coupled to the at least one arm, the blade being rotatable about the axis between a retracted position where the blade is positioned within the slot and an extended position where the blade extends outwardly from the body.

    Nanostructured thermoplastic polyimide films

    公开(公告)号:US10907026B2

    公开(公告)日:2021-02-02

    申请号:US14698467

    申请日:2015-04-28

    Inventor: Heshmat Aglan

    Abstract: Structured films containing multi-walled carbon nanotubes (“MWCNTs”) have enhanced mechanical performance in terms of strength, fracture resistance, and creep recovery of polyimide (“PI”) films. Preferably, the loadings of MWCNTs can be in the range of 0.1 wt % to 0.5 wt %. The strength of the new PI films dried at 60° C. increased by 55% and 72% for 0.1 wt % MWCNT and 0.5 wt % MWCNT loadings, respectively, while the fracture resistance increased by 23% for the 0.1 wt % MWCNTs and then decreases at a loading of 0.5 wt % MWCNTs. The films can be advantageously be created by managing a corresponding shift in the annealing temperature at which the maximum strength occurs as the MWCNT loadings increase.

    NANOCELLULOSIC COMPOSITIONS
    44.
    发明申请

    公开(公告)号:US20190048147A1

    公开(公告)日:2019-02-14

    申请号:US16028127

    申请日:2018-07-05

    Abstract: The invention relates to a method of manufacturing a nanocellulosic composition comprising cellulose nanoparticles and/or nanoparticles. The nanocellulosic compositions are useful in the manufacturing of biodegradable plastics. The invention also includes a method of manufacturing biodegradable plastics using such nanocellulosic compositions.

    Nanostructured thermoplastic polyimide films
    47.
    发明授权
    Nanostructured thermoplastic polyimide films 有权
    纳米结构热塑性聚酰亚胺薄膜

    公开(公告)号:US09034426B2

    公开(公告)日:2015-05-19

    申请号:US13678914

    申请日:2012-11-16

    Inventor: Heshmat Aglan

    Abstract: Structured films containing multi-walled carbon nanotubes (“MWCNTs”) have enhanced mechanical performance in terms of strength, fracture resistance, and creep recovery of polyimide (“PI”) films. Preferably, the loadings of MWCNTs can be in the range of 0.1 wt % to 0.5 wt %. The strength of the new PI films dried at 60° C. increased by 55% and 72% for 0.1 wt % MWCNT and 0.5 wt % MWCNT loadings, respectively, while the fracture resistance increased by 23% for the 0.1 wt % MWCNTs and then decreases at a loading of 0.5 wt % MWCNTs. The films can be advantageously be created by managing a corresponding shift in the annealing temperature at which the maximum strength occurs as the MWCNT loadings increase.

    Abstract translation: 含有多壁碳纳米管(“MWCNT”)的结构膜在聚酰亚胺(“PI”)膜的强度,耐断裂性和蠕变恢复方面具有增强的机械性能。 优选地,MWCNT的负载量可以在0.1重量%至0.5重量%的范围内。 在60℃下干燥的新PI膜的强度分别对于0.1重量%MWCNT和0.5重量%MWCNT负载分别增加了55%和72%,而0.1重量%MWCNT的耐断裂性提高了23%,然后 在负载量为0.5wt%的MWCNT时减少。 可以有利地通过管理当MWCNT负载增加时发生最大强度的退火温度的相应偏移来产生膜。

    IMMORTALIZED HUMAN PROSTATE CELL LINES
    48.
    发明申请
    IMMORTALIZED HUMAN PROSTATE CELL LINES 审中-公开
    完全人性化的细胞细胞系

    公开(公告)号:US20140286868A1

    公开(公告)日:2014-09-25

    申请号:US14296676

    申请日:2014-06-05

    Abstract: Immortalized human cell lines derived from prostate cells are disclosed. Immortalized cells derived from a human epithelial prostate tissue cancer tumor are provided, as well as immortalized cells derived from healthy human epithelial prostate tissue from the same patient. Methods for utilizing such immortalized cell lines for researching, screening, and evaluating antimalignancy therapies and drug candidates are also disclosed.

    Abstract translation: 公开了源自前列腺细胞的永生化人细胞系。 提供源自人上皮前列腺组织癌肿瘤的永生化细胞,以及衍生自来自同一患者的健康人上皮前列腺组织的永生化细胞。 还公开了利用这种永生化细胞系研究,筛选和评估抗偏倚药物和候选药物的方法。

Patent Agency Ranking